Skip to main content
Premium Trial:

Request an Annual Quote

More Cuts at Bruker Will Save Company $3M A Year; CEO Takes 20 Percent Pay Cut in 05

NEW YORK, Dec. 20 (GenomeWeb News) - Bruker BioSciences announced another round of cost-cutting and restructuring today that will save the company $3 million a year, and another $1 million next year.


Bruker will move all its German administrative and life-science business activities to its site in Bremen, and its German nuclear, biological, and chemical detection business to its Leipzigsite. Moreover, the UKoperations of subsidiaries Bruker AXS and Bruker Daltonics will be combined into one, based in Coventry.


In addition, Bruker will cut costs throughout the company, particularly at its non-profitable USsubsidiaries in Billerica, Mass., and Madison, Wis.


Bruker's CEO Frank Laukien will take a 20 percent pay cut next year. Combined with pay cuts for other managers and other temporary measures, this will save the company another $1 million in 2005.


Bruker has also incorporated sales subsidiaries in several countries "where the business volume has reached critical mass," according to a company statement.


A Bruker spokesperson did not know whether the cost-saving measures, which will be fully implemented in the second half of 2005, will result in job cuts.


This is Bruker's second round of restructuring this year. In September, the company laid off 60 staffers and reorganized its business to save $6 million per year.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.